par Berghmans, Thierry 
;Grigoriu, Bogdan;Giroux-Leprieur, Étienne E.;Revel, Marie Pierre
Référence Revue des Maladies Respiratoires Actualites, 11, 3, page (218-225)
Publication Publié, 2019-10-01
;Grigoriu, Bogdan;Giroux-Leprieur, Étienne E.;Revel, Marie PierreRéférence Revue des Maladies Respiratoires Actualites, 11, 3, page (218-225)
Publication Publié, 2019-10-01
Article révisé par les pairs
| Résumé : | Therapeutic algorithm for lung cancer is depending on histology, patient's functional status and disease extent. The international TNM classification, accepted by both UICC and AJCC, is routinely used for non-small cell lung cancer management and is recommended for small cell lung cancer even though for the latter, the Veterans’ Administration classification is preferred for therapeutic decision. The aim of this article is to review the 8th TNM classification, its practical impact and the IASLC Staging Committee proposals regarding some specific clinical situations. |
